Developed by Sarepta Therapeutics, Elevidys is a one-time, intravenous treatment that uses adeno-associated virus (AAV) ...

Families began receiving calls from doctors last week to arrange treatments for new Givinostat drug after a campaign by the ...

Sarepta Therapeutics (NASDAQ:SRPT) and its partner Roche (OTCQX:RHHBY) received a 'go ahead' from the regulatory body in U.K.

A number of strategies can help to ensure adequate joint care to best manage joint pain and stiffness in Duchenne muscular dystrophy (DMD).

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...

Columnist Shalom Lim stood up for his right to inclusive access to a major sporting event — and a local soccer club responded ...

Just a few weeks after Avidity Biosciences made a stir with new data on its experimental therapy for Duchenne muscular dystrophy ... as it has other clinical-stage projects on the go, including ...

Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.

The increased physical activity noted during the early stages of treatment may have ... that the underlying molecular defect in Duchenne muscular dystrophy was affected by physical activity ...

to treat Duchenne muscular dystrophy (DMD) in patients aged 6 years and older who can walk. Conditional marketing authorization is granted when the benefit of immediate availability outweighs the ...